Correlation Between Coya Therapeutics, and Pimco New

Can any of the company-specific risk be diversified away by investing in both Coya Therapeutics, and Pimco New at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Coya Therapeutics, and Pimco New into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Coya Therapeutics, Common and Pimco New York, you can compare the effects of market volatilities on Coya Therapeutics, and Pimco New and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Coya Therapeutics, with a short position of Pimco New. Check out your portfolio center. Please also check ongoing floating volatility patterns of Coya Therapeutics, and Pimco New.

Diversification Opportunities for Coya Therapeutics, and Pimco New

-0.29

Correlation Coefficient

Coya Therapeutics,  Pimco New

Very good diversification

The 3 months correlation between Coya and Pimco is -0.29. Overlapping area represents the amount of risk that can be diversified away by holding Coya Therapeutics, Common and Pimco New York in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pimco New York and Coya Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Coya Therapeutics, Common are associated (or correlated) with Pimco New. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pimco New York has no effect on the direction of Coya Therapeutics, i.e., Coya Therapeutics, and Pimco New go up and down completely randomly.

Pair Corralation between Coya Therapeutics, and Pimco New

Given the investment horizon of 90 days Coya Therapeutics, Common is expected to generate 5.87 times more return on investment than Pimco New. However, Coya Therapeutics, is 5.87 times more volatile than Pimco New York. It trades about 0.05 of its potential returns per unit of risk. Pimco New York is currently generating about -0.09 per unit of risk. If you would invest  597.00  in Coya Therapeutics, Common on May 7, 2025 and sell it today you would earn a total of  37.00  from holding Coya Therapeutics, Common or generate 6.2% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	98.39%
Values	Daily Returns

Coya Therapeutics, Common  vs.  Pimco New York

Coya Therapeutics, Common

Risk-Adjusted Performance

Soft

Compared to the overall equity markets, risk-adjusted returns on investments in Coya Therapeutics, Common are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Coya Therapeutics, may actually be approaching a critical reversion point that can send shares even higher in September 2025.

Pimco New York

Risk-Adjusted Performance

Weakest

Over the last 90 days Pimco New York has generated negative risk-adjusted returns adding no value to fund investors. Despite nearly stable basic indicators, Pimco New is not utilizing all of its potentials. The recent stock price disturbance, may contribute to mid-run losses for the stockholders.

Pair Trading with Coya Therapeutics, and Pimco New

The main advantage of trading using opposite Coya Therapeutics, and Pimco New positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Coya Therapeutics, position performs unexpectedly, Pimco New can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pimco New will offset losses from the drop in Pimco New's long position.

The idea behind Coya Therapeutics, Common and Pimco New York pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.